Methods for measuring the insulin receptor alpha subunit

Abstract

Presence of free insulin receptor α-subunit in blood was discovered. Furthermore, methods for measuring the insulin receptor α-subunit was provided, the method comprising the steps of contacting the insulin receptor α-subunit in a blood sample with an antibody recognizing the insulin receptor α-subunit, and detecting the binding between the two. Measurement of the free insulin receptor α-subunit in the blood is useful for evaluating risk factors for diabetes.In addition, the measurement methods of the present invention showed that concentrations of the free insulin receptor α-subunit in the blood of diabetes or cancer patients are significantly high. Free insulin receptor α-subunit in blood is useful as a marker for diabetes or cancer.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS[0001]This application is a divisional of U.S. application Ser. No. 10 / 554,561, filed Oct. 4, 2006, which is the U.S. National Stage entry under §371 of International Application No. PCT / JP2004 / 005412, filed Apr. 15, 2004, which claims benefit of Japanese Patent Application No. 2003-121955, filed Apr. 25, 2003 and Japanese Patent Application No. 2003-433303, filed Dec. 26, 2003; the disclosures of each are herein incorporated by reference in their entirety.TECHNICAL FIELD[0002]The present invention relates to methods for measuring a free insulin receptor α-subunit in blood. The present invention also relates to methods for diagnosing diabetes and cancer.BACKGROUND ART[0003]Insulin is a hormone that plays an important role in the metabolic regulation of glucose, an energy source for living organisms. Produced in pancreatic Langerhans β cells, insulin acts on cells carrying insulin receptors and promotes the uptake of glucose by these cells. The ...

AI Technical Summary

Benefits of technology

[0063]Alternatively, domain peptides of the insulin receptor α-subunit can be used as an immunogen. Domain peptides used as an immunogen can be easily synthesized using a peptide synthesizer. Synthetic peptides can be prepared as immunogens by linking them to carrier proteins.

[0072]On the other hand, to obtain the antibodies used in the present invention as polyclonal antibodies, blood is drawn from individuals whose antibody titer has increased after immunization, and the sera are separated to obtain anti-sera. Immunoglobulins are purified from anti-sera by known methods to prepare the antibodies to be used in the present invention. If immunoaffinity chromatography using insulin receptor α-subunit as a ligand is used in combination with immunoglobulin purification, insulin receptor α-subunit-specific antibodies can be obtained.

[0101]Although the steps of separating the solid phase from the liquid phase as well as washing steps are required in all heterogeneous immunoassays exemplified herein, these steps can easily be performed using immunochromatography, which is a variation of the sandwich method.

[0103]As a result, presence of the insulin receptor α-subunit can be detected using as an indicator the signals of the labeled antibodies remaining at the position of the immobilized antibodies. If the labeled antibodies are preloaded on the upstream in the porous carrier, all reactions will be initiated and completed by simply dropping the sample solution, resulting in the construction of an extremely convenient reaction system. In immunochromatography, labeled components that can be distinguished macroscopically, such as colored particles, can be combined to construct an analytical device that does not even need a special reader.

[0127]As another method for isolating the aforementioned immunologically equivalent protein, hybridization screening can be utilized. For example, those skilled in the art can easily use a polynucleotide comprising the nucleotide sequence of SEQ ID NO: 1, or a fragment thereof to isolate DNAs highly homologous thereto. Subsequent selection of DNAs that encode proteins immunologically equivalent to the polypeptide comprising the amino acid sequence of SEQ ID NO: 2 from thus-isolated DNAs can also be readily carried out by those skilled in the art.

Problems solved by technology

As a result, the insulin receptor α-subunit existing in the blood in a free form was revealed to hinder insulin action and cause hyperglycemia.

Images